Hardy B - Search Results

1

A monoclonal antibody against a human B lymphoblastoid cell line induces tumor regression in mice.

Hardy B, Yampolski I, Kovjazin R, Galli M, Novogrodsky A. Hardy B, et al. Cancer Res. 1994 Nov 15;54(22):5793-6. Cancer Res. 1994. PMID: 7954401

2

A monoclonal antibody to human B lymphoblastoid cells activates human and murine T lymphocytes.

Hardy B, Dotan D, Novogrodsky A. Hardy B, et al. Cell Immunol. 1989 Jan;118(1):22-9. doi: 10.1016/0008-8749(89)90354-7. Cell Immunol. 1989. PMID: 2783390

3

Activation of human lymphocytes by a monoclonal antibody to B lymphoblastoid cells; molecular mass and distribution of binding protein.

Hardy B, Galli M, Rivlin E, Goren L, Novogrodsky A. Hardy B, et al. Cancer Immunol Immunother. 1995 Jun;40(6):376-82. doi: 10.1007/BF01525388. Cancer Immunol Immunother. 1995. PMID: 7627994 Free PMC article.

4

A lymphocyte-activating monoclonal antibody induces regression of human tumors in severe combined immunodeficient mice.

Hardy B, Kovjazin R, Raiter A, Ganor N, Novogrodsky A. Hardy B, et al. Proc Natl Acad Sci U S A. 1997 May 27;94(11):5756-60. doi: 10.1073/pnas.94.11.5756. Proc Natl Acad Sci U S A. 1997. PMID: 9159146 Free PMC article.

5

Immune stimulatory and anti-tumor properties of anti-CD3 and BAT monoclonal antibodies: a comparative study.

Hardy B, Kovjazin R, Raiter A, Ganor N, Novogrodsky A. Hardy B, et al. Hum Antibodies. 1997;8(2):95-8. Hum Antibodies. 1997. PMID: 9289394

6

Monoclonal antibodies against native ovarian tumor cells: specificity and characterization of the antigen. A preliminary report.

Wasserman L, Neri A, Kaplan B, Manor Y, Galli M, Hardy B. Wasserman L, et al. Among authors: hardy b. J Cancer Res Clin Oncol. 1995;121(7):387-92. doi: 10.1007/BF01212943. J Cancer Res Clin Oncol. 1995. PMID: 7543483

7

Activation of lymphocytes by BAT and anti CTLA-4: comparison of binding to T and B cells.

Raiter A, Novogrodsky A, Hardy B. Raiter A, et al. Among authors: hardy b. Immunol Lett. 1999 Aug 3;69(2):247-51. doi: 10.1016/s0165-2478(99)00081-4. Immunol Lett. 1999. PMID: 10482359

8

CD4+ T lymphocytes as a primary cellular target for BAT mAb stimulation.

Raiter A, Rodionov G, Novogrodsky A, Hardy B. Raiter A, et al. Among authors: hardy b. Int Immunol. 2000 Nov;12(11):1623-8. doi: 10.1093/intimm/12.11.1623. Int Immunol. 2000. PMID: 11058582

9

BAT monoclonal antibody immunotherapy of human metastatic colorectal carcinoma in mice.

Hardy B, Morgenstern S, Raiter A, Rodionov G, Fadaeev L, Niv Y. Hardy B, et al. Cancer Lett. 2005 Nov 18;229(2):217-22. doi: 10.1016/j.canlet.2005.06.046. Epub 2005 Aug 24. Cancer Lett. 2005. PMID: 16122870

10

Treatment with BAT monoclonal antibody decreases tumor burden in a murine model of leukemia/lymphoma.

Hardy B, Indjiia L, Rodionov G, Raiter A, Inbal A. Hardy B, et al. Int J Oncol. 2001 Nov;19(5):897-902. doi: 10.3892/ijo.19.5.897. Int J Oncol. 2001. PMID: 11604985

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

419 results

Search Page

Filters